kuvura kanseri y'ibihaha bishya intambwe ya 2020

Muri 2020, hari intambwe igaragara yatewe mu kuvura kanseri y'ibihaha, harimo kwemeza uburyo bushya bwo kuvura no gukingira indwara, bitanga umusaruro ushimishije ndetse n'uburyo bwihariye ku barwayi. Izi ntambwe zatanzwe zatanze uburyo bushya kubarwanya kanseri y'ibihaha, bakemura ihinduka ry’imiterere yihariye kandi bakongerera umubiri imbaraga zo kurwanya indwara. Umwaka w'iterambere: Urufunguzo Uburyo bushya bwo kuvura kanseri y'ibihaha2020 yaranze umwaka ukomeye mu kurwanya kanseri y'ibihaha. Mu gihe umwaka wiganjemo icyorezo ku isi, abashakashatsi n'abaganga bakomeje guhana imbibi z'ubuvuzi. Ibintu byinshi byizewe byagaragaye, bitanga ibyiringiro kubarwayi no kuvugurura imiterere yubuvuzi bwa kanseri yibihaha. Ikigo cy’ubushakashatsi cya Kanseri ya Shandong Baofa cyakurikiraniraga hafi ayo majyambere.Ubuvuzi bugamije: Ubuvuzi bwa Precision Ubuvuzi buteganijwe, bugamije kwibasira intege nke zihariye mu ngirabuzimafatizo za kanseri, bwabonye iterambere rigaragara muri 2020. Ubu buvuzi akenshi butera ingaruka nke ugereranije na chimiotherapie gakondo kuko byibasira kanseri ya kanseri ya EGFR idahinduka ya selile ya EGFR. Muri 2020, hashyizweho uburyo bushya kandi bunoze bwa EGFR inhibitor, butanga ubuzima bwiza butagira amajyambere kubarwayi bafite ihindagurika. Ibisekuru bishya-inhibitor bikunze kunesha uburyo bwo kurwanya bigabanya imikorere yibiyobyabwenge mbere. By'umwihariko, abakozi bareba EGFR exon 20 insertion mutation yerekanye ibikorwa bitanga icyizere.Urugero, umwe mubakozi ni amivantamab. Imbonerahamwe ikurikira irerekana ibisubizo byikigereranyo cyamavuriro ya amivantamab: Icyiciro cyikigereranyo Muri rusange Igipimo cyo Gusubiza (ORR) Igihe cyo gusubiza (DoR) Icyiciro cya I 40% 11.1 amezi Source: FDAALK Inhibitor: Kwagura Amahitamo yo KuvuraAnaplastique lymphoma kinase (ALK) itondekanya nubundi buryo bwo guhindura ibinyabiziga muri NSCLC. Inzitizi nyinshi za ALK zimaze kuboneka, kandi muri 2020, ubushakashatsi bwibanze ku kunesha imiti ndetse no guteza imbere imiti myinshi. Hakozwe kandi ubushakashatsi bushya bwo kuvura indwara ziterwa na kanseri y'ibihaha ALK-nziza.Immunotherapy: Gukoresha imbaraga za Immune SystemImmunotherapy, yongerera umubiri imbaraga z'umubiri kurwanya kanseri, byakomeje kuba igice kinini cy’iterambere ry’ubuvuzi bwa kanseri y'ibihaha mu 2020. Inzitizi za kanseri zerekana ibizamini bya kanseri, nka pembrolizumab. Muri 2020, ubushakashatsi bwerekanye imikoreshereze yibi biyobyabwenge mugihe cyambere cyindwara, harimo nyuma yo kubagwa cyangwa hamwe na chimiotherapie. Ubu bushakashatsi bwerekanye ko ubudahangarwa bw'umubiri bushobora kuzamura igipimo cyo kubaho no kugabanya ibyago byo kongera kubaho ku barwayi bamwe na bamwe.Combination Immunotherapy RegimensAbashakashatsi kandi bakoze ubushakashatsi ku guhuza imiti itandukanye ikingira indwara kugira ngo barusheho gukora neza. Guhagarika ibice bibiri, ukoresheje ubwoko bubiri butandukanye bwo kwirinda indwara, bwerekanye amasezerano mubarwayi bamwe na bamwe batitabira ubudahangarwa bw'umubiri umwe. Igeragezwa rya Clinical ryakomeje kunonosora ubwo buryo bwo guhuza kugira ngo hamenyekane abarwayi bashobora kungukirwa cyane.Uruhare rwo Kwipimisha BiomarkerIterambere mu buvuzi bugamije kuvura no gukingira indwara ryagaragaje akamaro ko kwipimisha biomarker muri kanseri y'ibihaha. Muri 2020, hibanzwe cyane ku kwipimisha ku buryo butandukanye bw’imihindagurikire y’imiterere n’imvugo ya PD-L1 kugira ngo bayobore ibyemezo byo kuvura. Ubu buryo bwihariye butuma abarwayi bahabwa imiti ikwiye kandi ifatika kuri kanseri yabo yihariye.Ikigo cy’ubushakashatsi cya kanseri ya Shahandong Baofa gishimangira akamaro ko kwipimisha byuzuye kugira ngo bigere ku musaruro mwiza. Kureba imbere: Icyerekezo kizaza imiti mishya yo kuvura kanseri y'ibihaha yashyizeho inzira yo kurushaho gutera imbere mumyaka iri imbere. Ubushakashatsi burimo gukorwa bwibanze ku guteza imbere imiti mishya igamije, kunoza ingamba zo gukingira indwara, no kumenya biomarkers nshya. Intego nyamukuru ni ugutezimbere uburyo bunoze kandi bwihariye bwo kuvura ubuzima bwiza nubuzima bwiza kubarwayi bose barwaye kanseri yibihaha.Umwanzuro2020 wari umwaka witerambere ryinshi mukuvura kanseri yibihaha. Kwemeza uburyo bushya bwo kuvura no gukingira indwara, hamwe no kurushaho kwibanda ku gupima biomarker, byahinduye imiterere yo kwita kuri kanseri y'ibihaha. Iterambere ritanga ibyiringiro ku barwayi n'imiryango yabo kandi rikagaragaza akamaro ko gukomeza ubushakashatsi no guhanga udushya mu kurwanya iyi ndwara yangiza. Tekereza gusura Shandong Baofa Ikigo Cyubushakashatsi cya Kanseri urubuga kubindi bisobanuro kubigeragezo bivura no kuvura kanseri.